Skip to content
Home/Companies/Biotech/Creasallis
CR

Creasallis

Biotech·United Kingdom·Active·3yr hold

Creasallis is a biotech company, headquartered in United Kingdom.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Creasallis?

Creasallis is currently owned by BlueYard Capital through BlueYard Capital Fund III (2022 vintage), since 2023.

Hand-verified · updated 2026-07-17

BlueYard Capital
Investor
BlueYard Capital
BlueYard Capital Fund III · 2022 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from BlueYard Capital Fund III

Other portfolio companies in the same fund.

Aerska
Active
BiotechIreland· 2025
Corintis
Active
Deep TechSwitzerland· 2025
Manex AI
Active
AI/MLGermany· 2025
Miren
Active
Cloud InfrastructureUnited States· 2025
ZeroPhase
Active
Aerospace & DefenceGermany· 2025
clock.bio
Active
BiotechUnited Kingdom· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings